Marshall Wace, LLP
- SEC CIK
- 0001318757
- Latest filing
- Aug 13, 2026
CRSP holding history
CRISPR Therapeutics AG in every 13F filed by Marshall Wace, LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRSP overviewAll 13F holders of CRSPFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −393,295−100.0% | Sold out | Holders |
| Q1 2025 | 393,295 | $13.4M | <0.1% | +393,295 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −186,591−100.0% | Sold out | Holders |
| Q2 2024 | 186,591 | $10.1M | <0.1% | +186,591 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −3,200−100.0% | Sold out | Holders |
| Q4 2023 | 3,200 | $200.3K | <0.1% | −132,747−97.6% | Reduced | Holders |
| Q3 2023 | 135,947 | $6.17M | <0.1% | −321,061−70.3% | Reduced | Holders |
| Q2 2023 | 457,008 | $25.7M | 0.1% | +457,008 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −10,893−100.0% | Sold out | Holders |
| Q3 2022 | 10,893 | $712.0K | <0.1% | +10,893 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −255,727−100.0% | Sold out | Holders |
| Q3 2021 | 255,727 | $28.6M | 0.1% | +255,727 | New | Holders |